Company / Current Liabilities
Fortress Biotech, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$49.7M
FY2025
5-year range
$49.7M / $127.7M
FY2021-FY2025
Trend
-30.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has declined for 3 consecutive years, from $128M in FY2022 to $50M in FY2025.
Based on SEC 10-K filings.
$50M in FY2025 with a 5-year CAGR of +1.7%.
Improved from $85M to $50M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -27.0%
- 5-Year CAGR
- +1.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Fortress Biotech, Inc.'s current liabilities has declined for 3 consecutive years.
- 5-year CAGR of +1.7%, indicating consistent growth.
- In FY2025, current liabilities decreased 30.3% year-over-year.
- Peak current liabilities was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $49.7M | -30.3% |
| FY2024 | $71.4M | -15.9% |
| FY2023 | $84.9M | -33.5% |
| FY2022 | $127.7M | +26.4% |
| FY2021 | $101.0M | +121.5% |
| FY2020 | $45.6M | +0.0% |
| FY2019 | $45.6M | -18.0% |
| FY2018 | $55.6M | -17.5% |
| FY2017 | $67.4M | +19.2% |
| FY2016 | $56.6M | +434.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026